Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose

This study is currently recruiting participants.
Verified April 2013 by Zhejiang Beta Pharma Inc.
Sponsor:
Information provided by (Responsible Party):
Zhejiang Beta Pharma Inc.
ClinicalTrials.gov Identifier:
NCT01465243
First received: November 1, 2011
Last updated: April 3, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)